|
Addiction Technology Transfer Center
|
Resource Development
|
SAMHSA
|
NIDA
|
Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research.
|
|
Adjuvant Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID, NCI
|
Staff from all NIAID Divisions, program staff from BARDA, and regulatory staff from FDA exchange information about ongoing programs related to novel adjuvants for infectious disease vaccines, identify high priority research areas (and gap areas), and discuss ideas to accelerate progress in adjuvant research through better access to information and resources.
|
|
Administration for Community Living (ACL) - NIA Partnership
|
Other
|
ACL
|
NIA, NIDCR, NIMH, NIMHD, NINDS, NINR
|
This group is made up of representatives from the Administration for Community Living/Administration on Aging and the National Institute on Aging who are working to identify evidence-based interventions that are ready for dissemination and implementation in community programs and collaboratively support their translation into the community. These efforts may also include setting up ways to evaluate the success of these dissemination and implementation efforts. Areas of interest identified to date include Family Caregiving, Exercise/Physical Activity, Nutrition, Elder Mistreatment/Abuse/Financial Fraud, Falls, Driving, Sleep, Medication Management, Depression/Mental Health, Living with Long-Term Disability, Stroke, and Alzheimer’s Disease.
|
|
Administration of Comprehensive Assessment of Occupationally-Relevant Exposures
|
Research Initiative
|
CDC
|
NIEHS
|
This task order provides financial support for NIOSH personnel to travel to, attend, and participate in several National Toxicology Program (NTP) meetings held in Research Triangle Park, NC, and Washington, DC. These included Interagency Committee for Chemical Evaluation and Coordination meetings, NTP Technical Report meetings, NTP Board of Scientific Counselors meetings, Report on Carcinogens meetings, NTP Executive Committee Meetings, and ad hoc meetings addressing specific NTP issues. All of these meetings were aimed at investigating, defining, or reporting hazards associated with exposure to environmental chemicals. Many of the exposures are occupational and NIOSH personnel provide expert opinion on chemical exposures linked to cancer, respiratory disease, development and reproductive disorders, neurotoxicity, and immunological toxicity.
|
|
Adolescent Health Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NICHD, NIDA, NIMH
|
The Adolescent Health Working Group was established under the Healthy People 2020 Initiative. The goal of this workgroup is to improve the healthy development, health, safety, and well-being of adolescents and young adults. This interagency workgroup focuses on three current near-term priorities: (1) enrolling eligible adolescents in Medicaid and Children''s Health Insurance Program; (2) preventing and addressing mental disorders and promoting mental wellness in adolescents; and (3) youth engagement. NIMH staff worked with SAMHSA to draft a framework of strategies to address mental disorders and promote mental wellness in adolescents. This framework identified opportunities that could be implemented with existing resources, and proposed ideas would need additional resources.
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NINDS, NIAID
|
The Advanced Anticonvulsant System Interagency Product Team is a Department of Defense-led effort to facilitate activities, both research and regulatory, related to the FDA approval of midazolam for use in treating nerve agent exposure.
|
|
Advancing Regulatory Science through Novel Research and Science-Based Technologies
|
Research Initiative
|
FDA
|
OD/OSP, NCATS, NEI, NHLBI, NIBIB, NIDDK, NINDS, OD/DPCPSI/OSC
|
NIH and FDA have formed an interagency partnership to foster regulatory science, a specialized and inter-disciplinary area of biomedical research that serves to generate new knowledge and tools for assessing experimental therapies, preventives, and diagnostics. A key goal of this Regulatory Science program is to accelerate the development and use of new tools, standards and approaches to efficiently develop products and to more effectively evaluate product safety, efficacy and quality.
|
|
Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIEHS
|
The overall goal of the Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP) is to provide advice that will assist the nation in reducing the incidence and prevalence of childhood lead poisoning.
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NIAID
|
The Advisory Committee on Organ Transplantation (ACOT) was established to assist the HHS Secretary in enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, and assuring the public that the system is as effective and equitable as possible, thereby increasing public confidence in the integrity and effectiveness of the transplantation system.
|
|
Agency for Toxic Substances and Disease Registry Seminar Series
|
Meeting/ Workshop
|
ATSDR
|
NIEHS
|
A seminar series established to communicate Superfund Research Program (SRP) research findings at the Agency for Toxic Substances and Disease Registry (ATSDR) and to provide networking collaborative opportunities for SRP grantees. The series is jointly coordinated with SRP and ATSDR staff.
|